We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Study of LM-302 in Patients With Advance Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT05161390
Recruitment Status : Enrolling by invitation
First Posted : December 17, 2021
Last Update Posted : November 21, 2022
Information provided by (Responsible Party):
LaNova Medicines Limited ( LaNova Medicines Zhejiang Co., Ltd. )

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Enrolling by invitation
Estimated Primary Completion Date : March 10, 2025
Estimated Study Completion Date : June 8, 2025